Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies-Reference-Cited by-同舟云学术

Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies

Published:2021-05-18 Issue:4 Volume:8 Page:3327-3338
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Jorbenadze Ana¹,Fudim Marat²³,Mahfoud Felix⁴,Adamson Phillip B.⁵,Bekfani Tarek⁶,Wachter Rolf⁷,Sievert Horst⁸,Ponikowski Piotr P.⁹,Cleland John G. F.¹⁰,Anker Stefan D.¹¹¹²

Affiliation:

1. Tbilisi Heart and Vascular Clinic Tbilisi Georgia

2. Division of Cardiology Duke University Medical Center Durham NC USA

3. Duke Clinical Research Institute Durham NC USA

4. Department of Internal Medicine III, Cardiology, Angiology, and Intensive Care Medicine Saarland University Saarbrücken Germany

5. Abbott Los Angeles CA USA

6. Department of Internal Medicine I, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Magdeburg Otto von Guericke University Magdeburg Germany

7. Clinic and Polyclinic for Cardiology University Hospital Leipzig Leipzig Germany

8. CardioVascular Center Frankfurt Frankfurt Germany

9. Centre for Heart Diseases University Hospital Wroclaw Poland

10. Robertson Centre for Biostatistics University of Glasgow Glasgow UK

11. Division of Cardiology and Metabolism – Heart Failure, Cachexia & Sarcopenia, Department of Cardiology, Campus Virchow‐Klinikum Charité – Universitätsmedizin Berlin Berlin Germany

12. Berlin‐Brandenburg Centre for Regenerative Therapies (BCRT) Charité – Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13361

Reference83 articles.

1. Heart Failure with Preserved Ejection Fraction in Older Adults

2. Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines

3. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF

4. Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives;Shear FE;Am J Cardiovasc Dis,2019

5. The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction;Life;2023-04-13

2. Promising directions in the treatment of chronic heart failure: improving old or developing new ones?;Bulletin of Siberian Medicine;2022-10-15